SOLID SALT FORMS OF PYRROLE-SUBSTITUTED 2-INDOLINONE Russian patent published in 2010 - IPC C07D403/06 A61K31/404 A61P35/00 

Abstract RU 2399619 C2

FIELD: chemistry.

SUBSTANCE: invention relates to novel salt forms of a base, where the base is (2-pyrrolidin-1-yl-ethyl)-amide 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylc acid, and where the salt form is selected from a group consisting of citric and phosphate salts, and to their solvates and polymorphs. The invention also relates to a polymorph (form 1) of a phosphate salt in claim 2, to a pharmaceutical composition, to a method of modifying catalytic activity of protein kinase, to a method of preventing or treating protein kinase related disorders in the body, to a method of obtaining crystals of the phosphate salt of the base in claim 1, to a method of obtaining polymorphs of the phosphate salt in claim 2, to a method of obtaining crystals of the citric salt of the base in claim 1, as well as to use of the phosphate salt in claim 2 and citric salt in claim 5.

EFFECT: obtaining new biologically active compounds which modulate protein kinase activity.

17 cl, 8 ex, 8 tbl, 6 dwg

Similar patents RU2399619C2

Title Year Author Number
POLYMORPHS OF PYRROL-SUBSTITUTED 2-INDOLINONE PROTEINKINASE INHIBITORS 2004
  • Sun' Chantsjuan'
  • Foster Todd P.
  • Khan F'Juzen
  • Khouli Majkl
  • Tamann Tom
RU2335502C2
PURIFIED PYRROLOQUINOLINYL-PYRROLIDINE-2,5-DIONE COMPOSITIONS AND METHODS OF OBTAINING AND APPLICATION THEREOF 2010
  • Rid Dehvid P.
  • Barns Nil R.
  • Kejn Dzhon K.
  • Li Kristofer A.
  • Chehn' Tszjan'-Se
  • Redmond Martin P.
RU2556205C2
SALT FORM OF HUMAN HISTONE METHYLTRANSERASE EZH2 INHIBITOR 2013
  • Kuntts Kevin Uejn
  • Khuan Kuan-Chun
  • Choi Khieong Vook
  • Sanders Kristen
  • Mate Stiven
  • Chanda Arani
  • Fan Frenk
RU2658911C2
SOLID FORMS OF THE COMPOUND MODULATING THE KINASES 2016
  • Ibrakhim Prabkha N.
  • Vajzor Geri Konrad
RU2730506C2
3-[1,2,3,6-TETRAHYDROPYRIDIN-2-YL]PYRIDINE GLUTARATE OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF 2019
  • Mazurov, Anatoly
RU2823979C2
CRYSTALLINE FORM OF COMPOUND SUPPRESSING PROTEIN KINASE ACTIVITY AND THE USE THEREOF 2017
  • Lyan, Tsunsin
  • Ma, Yunbin
  • Khe, Vej
RU2744264C2
COMPOSITIONS AND METHODS WHICH CAN BE USED FOR TREATING PROLIFERATIVE DISEASES 2015
  • Dransfield, Daniel T.
  • Eathiraj, Sudharshan
  • Lapierre, Jean-Marc
  • Schwartz, Brian
  • Yu, Yi
RU2711500C2
NOVEL HYDROSULPHATE SALT 2006
  • Skvajr Kristofer Dzhon
  • Demattei Dzhon
  • Roberts Ronal'D Dzhon
  • Chuang Tsung-Khsun
  • Sharma-Singkh Gorkn
  • Pervez Mokhammed
  • Ford Dzhejms Gehr
  • Stori Richard Ehntoni
  • Dikkinson Pol Al'Fred
RU2418790C2
POLYMORPHOUS AND AMORPHOUS FORMS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINE[5,4,3-CD]INDOL-6-ON PHOSPHATE 2005
  • Liu Dzhia
  • Najjar Naresh
  • Guo Ming
  • Vu Zhen-Ping
  • Borer Bennett Shaplin
  • Shrirangam Aparna Nadig
  • Mitchell Mark Brajan
  • Li Ji
  • Chu Dzhan-Dzhon
RU2355691C2
DIARYLTHIOHYDANTOIN COMPOUND CRYSTAL 2020
  • Shen Chunli
  • Chen Shenglin
  • Wang Ting
  • Liu Fei
  • Tian Xin
  • Guo Yuying
  • Zhang Lin
  • Wu Jiahu
RU2810214C2

RU 2 399 619 C2

Authors

Sun Changkvan Kehlvin

Kholi Majkl

Dates

2010-09-20Published

2006-09-08Filed